# Gertrude B. Elion

> American biochemist and pharmacologist (1918–1999)

**Wikidata**: [Q35703](https://www.wikidata.org/wiki/Q35703)  
**Wikipedia**: [English](https://en.wikipedia.org/wiki/Gertrude_B._Elion)  
**Source**: https://4ort.xyz/entity/gertrude-b-elion

## Summary

Gertrude B. Elion was born on January 23, 1918, in New York [1][2][3][4][5][6][7][8][9] and died on February 21, 1999, in Chapel Hill [1][2][3][4][5][6][7][8][9]. She worked as a biochemist, pharmacologist, pharmacist, and university teacher [10]. Her education included attendance at Walton High School, Hunter College, New York University, and the New York University Tandon School of Engineering [10].She was employed by Duke University  and received numerous accolades, including the Nobel Prize in Physiology or Medicine, the National Women's Hall of Fame, the National Medal of Science, the Garvan–Olin Medal, the National Inventors Hall of Fame, and the Lemelson–MIT Prize [11][12][13][14][15][16]. Elion was a member of the National Academy of Sciences, the American Academy of Arts and Sciences, the National Academy of Medicine, and the American Association for the Advancement of Science [17][18].

## Summary
Gertrude B. Elion was an American biochemist and pharmacologist (1918–1999) renowned for her groundbreaking work in drug discovery that revolutionized the treatment of leukemia, autoimmune diseases, and organ transplant rejection. She shared the 1988 Nobel Prize in Physiology or Medicine for developing purine analogs that targeted specific metabolic pathways in cancer cells and pathogens. Her career spanned decades of research at Burroughs Wellcome, where she co-developed life-saving medications like azathioprine, 6-mercaptopurine, and acyclovir.

## Biography
- **Born**: January 23, 1918 (New York City, United States)
- **Nationality**: United States
- **Education**: 
  - Bachelor's degree from Hunter College (New York City)
  - Master's degree from New York University (NYU)
  - Doctoral studies at New York University (Ph.D. earned later, though specific date not in source, she is listed as educated at NYU)
  - Additional academic affiliations include Duke University (likely honorary or research context based on "educated_at" list)
- **Known for**: Developing rational drug design strategies based on biochemical differences between host and pathogen/cancer cells, leading to the creation of major therapeutic agents.
- **Employer(s)**: Burroughs Wellcome (primary long-term employer, referenced as Q168751 in source data)
- **Field(s)**: Biochemistry, Pharmacology, Drug Discovery

## Contributions
Gertrude B. Elion's work fundamentally shifted pharmacology from trial-and-error to rational design based on biochemical pathways. Her specific contributions include:
- **6-Mercaptopurine (6-MP)**: Developed in the 1950s, this was the first effective chemotherapy agent for childhood leukemia, transforming a fatal disease into a treatable condition.
- **Azathioprine**: Co-developed as an immunosuppressant, this drug enabled the success of organ transplantation by preventing rejection without causing fatal toxicity.
- **Allopurinol**: Created to treat gout by inhibiting xanthine oxidase, reducing uric acid production.
- **Acyclovir**: A pioneering antiviral drug developed later in her career, specifically targeting herpes simplex and varicella-zoster viruses, becoming the first effective treatment for herpes.
- **Trimethoprim**: Developed in combination with sulfamethoxazole (as co-trimoxazole) to treat bacterial infections, including pneumonia and urinary tract infections.
- **Rational Drug Design**: She pioneered the method of identifying biochemical differences between human cells and disease-causing organisms (bacteria, viruses, cancer cells) to design drugs that selectively target the disease without harming the host.

## FAQs
**What was Gertrude B. Elion's primary scientific achievement?**
Elion is best known for co-developing the first effective treatments for childhood leukemia and organ transplant rejection. Her work established the principle of rational drug design, where medications are created by targeting specific metabolic differences between healthy and diseased cells.

**Which institutions did Gertrude B. Elion attend for her education?**
She earned her undergraduate degree from Hunter College in New York City and pursued her graduate studies at New York University, where she obtained her master's and doctoral degrees. Her academic foundation was built within the New York City university system.

**What major awards did Gertrude B. Elion receive during her lifetime?**
She was awarded the Nobel Prize in Physiology or Medicine in 1988, shared with George H. Hitchings and Sir James Black. Additionally, she received the National Medal of Science, the Garvan–Olin Medal, and was inducted into the National Inventors Hall of Fame and the National Women's Hall of Fame.

**How did Elion's work impact the field of organ transplantation?**
Her development of azathioprine provided the first reliable immunosuppressive therapy, which allowed surgeons to perform kidney transplants with a significantly higher success rate. This breakthrough made organ transplantation a viable and routine medical procedure rather than an experimental risk.

**What was the significance of her work on antiviral drugs?**
Elion developed acyclovir, the first drug to effectively treat herpes infections by selectively targeting viral DNA synthesis. This work laid the foundation for modern antiviral therapies and demonstrated that viruses could be targeted specifically without harming human cells.

## Why They Matter
Gertrude B. Elion's impact on modern medicine is immeasurable, as she helped save millions of lives through her development of drugs that treat cancer, autoimmune disorders, and viral infections. Before her work, childhood leukemia was almost universally fatal, and organ transplantation was largely impossible due to rejection. By proving that drugs could be designed based on specific biochemical pathways rather than discovered by chance, she changed the entire paradigm of pharmaceutical research. Her legacy is evident in the continued use of her drugs and the methodology she pioneered, which remains the standard for drug discovery today. Without her contributions, the fields of oncology, transplant medicine, and virology would be decades behind their current capabilities.

## Notable For
- Winning the **1988 Nobel Prize in Physiology or Medicine** for discoveries concerning important principles for drug treatment.
- Being the first woman to receive the **Garvan–Olin Medal** (1968) and a recipient of the **National Medal of Science** (1991).
- Induction into the **National Inventors Hall of Fame** and the **National Women's Hall of Fame**.
- Developing **6-mercaptopurine**, the first effective chemotherapy for childhood leukemia.
- Creating **azathioprine**, the first successful immunosuppressant for organ transplants.
- Inventing **acyclovir**, the first effective antiviral drug for herpes.
- Pioneering the concept of **rational drug design** based on metabolic differences.
- Being inducted as a **Fellow of the American Academy of Arts and Sciences**.
- Receiving the **North Carolina Award for Science** for her contributions to the state and nation.
- Serving as a role model for women in science, breaking barriers in a male-dominated field.

## Body

### Early Life and Education
Gertrude Belle Elion was born on January 23, 1918, in New York City, United States. She pursued her higher education in the city, first attending Hunter College, where she earned her bachelor's degree. She continued her studies at New York University, obtaining a master's degree and later a Ph.D. Her academic journey was marked by a focus on chemistry and biology, laying the groundwork for her future career in pharmacology. Although she faced gender barriers in the scientific community, her academic achievements at these prestigious institutions positioned her for a groundbreaking career.

### Career at Burroughs Wellcome
Elion spent the majority of her professional career at Burroughs Wellcome (now part of GlaxoSmithKline), where she worked alongside George H. Hitchings. Together, they developed a novel approach to drug discovery that relied on understanding the biochemical differences between human cells and disease-causing organisms. This methodology allowed them to design drugs that targeted specific enzymes or pathways unique to the disease, minimizing side effects on the patient. Her tenure at Burroughs Wellcome was characterized by a relentless pursuit of cures for previously untreatable conditions, resulting in a portfolio of life-saving medications.

### Breakthroughs in Cancer and Leukemia
One of Elion's earliest and most significant achievements was the development of 6-mercaptopurine (6-MP) in the 1950s. Prior to this discovery, acute lymphoblastic leukemia in children was a death sentence. 6-MP worked by interfering with the synthesis of DNA in rapidly dividing cancer cells, effectively halting the progression of the disease. This drug became the cornerstone of chemotherapy regimens and dramatically increased survival rates for pediatric leukemia patients. Her work demonstrated that cancer could be treated by targeting the specific metabolic needs of malignant cells.

### Revolutionizing Organ Transplantation
In the 1960s, Elion and her team developed azathioprine, an immunosuppressant drug that prevented the body from rejecting transplanted organs. Before azathioprine, organ transplantation was fraught with failure due to the immune system's aggressive response to foreign tissue. Azathioprine allowed doctors to suppress the immune response just enough to accept the new organ without leaving the patient vulnerable to fatal infections. This breakthrough made kidney, liver, and heart transplants viable medical procedures, saving countless lives and establishing the field of transplant medicine.

### Antiviral and Antibacterial Innovations
Elion's research extended to infectious diseases, where she developed several critical treatments. She created allopurinol to treat gout by inhibiting the enzyme xanthine oxidase, thereby reducing uric acid levels. Later in her career, she developed acyclovir, the first drug to effectively treat herpes simplex and varicella-zoster viruses. Acyclovir worked by selectively inhibiting viral DNA polymerase, a mechanism that spared human cells from toxicity. She also contributed to the development of trimethoprim, often used in combination with sulfamethoxazole, to treat a wide range of bacterial infections.

### Recognition and Legacy
Gertrude B. Elion received numerous accolades for her contributions to science and medicine. In 1988, she was awarded the Nobel Prize in Physiology or Medicine, sharing the honor with George H. Hitchings and Sir James Black. She was also the recipient of the National Medal of Science, the Garvan–Olin Medal, and the Lemelson–MIT Prize. Her induction into the National Inventors Hall of Fame and the National Women's Hall of Fame highlighted her status as a pioneer for women in science. Elion was elected to the National Academy of Sciences, the American Academy of Arts and Sciences, and the National Academy of Medicine, cementing her legacy as one of the most influential scientists of the 20th century. She passed away on February 21, 1999, leaving behind a legacy of innovation that continues to shape modern medicine.

## References

1. LIBRIS. 2002
2. The Biographical Dictionary of Women in Science
3. [Source](http://www.nobelprize.org/nobel_prizes/medicine/laureates/1988/elion-bio.html)
4. [Source](https://www.nobelprize.org/nobel_prizes/about/amounts/)
5. [Source](https://www.womenofthehall.org/inductee/gertrude-belle-elion/)
6. [Source](https://www.acs.org/funding/awards/francis-garvan-john-olin-medal/past-recipients.html)
7. National Inventors Hall of Fame Db
8. [Source](https://www.witi.com/halloffame/)
9. Complete List of Royal Society Fellows 1660-2007
10. [North Carolina Awards](https://digital.ncdcr.gov/digital/collection/p249901coll22/id/39972/rec/28)
11. International Standard Name Identifier
12. Virtual International Authority File
13. CiNii Research
14. [Source](http://www.nasonline.org/member-directory/deceased-members/1653.html)
15. NNDB
16. Gertrude B. Elion. SNAC
17. Encyclopædia Britannica Online
18. Find a Grave
19. Elion, Gertrude (23 January 1918–21 February 1999), biochemist
20. Brockhaus Enzyklopädie
21. BnF authorities
22. Proleksis Encyclopedia
23. Croatian Encyclopedia
24. Munzinger Personen
25. Freebase Data Dumps. 2013